These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19740925)

  • 21. Influenza vaccine and Guillain-Barré syndrome: making informed decisions.
    Poland GA; Poland CM; Howe CL
    Lancet; 2013 Apr; 381(9876):1437-9. PubMed ID: 23622271
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
    Choe YJ; Cho H; Bae GR; Lee JK
    Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pandemic influenza: a priority for the neurological community.
    Lancet Neurol; 2009 Oct; 8(10):869. PubMed ID: 19747645
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
    Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
    Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccines and guillain-barre syndrome: the continuing question.
    Sejvar JJ
    Neurology; 2013 Oct; 81(18):1562-3. PubMed ID: 24166961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study.
    Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN
    Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 30. The self-controlled case series method for evaluating safety of vaccines.
    Hawken S; Wilson KR
    Med J Aust; 2012 Nov; 197(10):578-9. PubMed ID: 23163690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [H1N1 Pandemic flu vaccination: an update on December 18th 2009].
    Brouqui P; Lagier JC
    Ann Fr Anesth Reanim; 2010 Feb; 29(2):81-2. PubMed ID: 20153598
    [No Abstract]   [Full Text] [Related]  

  • 32. Influenza vaccination coverage among pregnant women--National 2009 H1N1 Flu Survey (NHFS).
    Ding H; Santibanez TA; Jamieson DJ; Weinbaum CM; Euler GL; Grohskopf LA; Lu PJ; Singleton JA
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S96-106. PubMed ID: 21640233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. China gears up for swine flu vaccination as virus spreads inland.
    Parry J
    BMJ; 2009 Sep; 339():b3778. PubMed ID: 19752075
    [No Abstract]   [Full Text] [Related]  

  • 34. Perspective: Swine-origin influenza: 1976 and 2009.
    Sencer DJ
    Clin Infect Dis; 2011 Jan; 52 Suppl 1():S4-7. PubMed ID: 21342898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging swine flu and increased report of AEFI to classical influenza vaccination.
    Wiwanitkit V
    Vaccine; 2009 Nov; 27(48):6651. PubMed ID: 19717134
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine].
    Siegrist CA
    Rev Med Suisse; 2010 Jan; 6(231):67-70. PubMed ID: 20196437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias.
    Hua W; Sun G; Dodd CN; Romio SA; Whitaker HJ; Izurieta HS; Black S; Sturkenboom MC; Davis RL; Deceuninck G; Andrews NJ
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):819-25. PubMed ID: 23625875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination?
    Li S; Zhu J
    Vaccine; 2012 Aug; 30(38):5585. PubMed ID: 22728223
    [No Abstract]   [Full Text] [Related]  

  • 39. Questioning the timeline of H1N1 flu vaccination contracts.
    Cohen D; Carter P
    Nature; 2010 Jul; 466(7304):315. PubMed ID: 20631779
    [No Abstract]   [Full Text] [Related]  

  • 40. Seasonal flu vaccine.
    Yadav RK
    Indian Pediatr; 2010 Aug; 47(8):722; author reply 722. PubMed ID: 20972291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.